Impact of contrast-induced acute kidney injury on outcomes in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention

Cardiovascular Revascularization Medicine

Volumn 14, Issue 5, 2013, Pages 253-257

  Kume, Kiyoshi ^a   Yasuoka, Yoshinori ^a   Adachi, Hidenori ^a   Noda, Yoshiki ^a   Hattori, Susumu ^a   Araki, Ryo ^a   Kohama, Yasuaki ^a   Imanaka, Takahiro ^a   Matsutera, Ryo ^a   Kosugi, Motohiro ^a   Sasaki, Tatsuya ^a  

^a MINAMI OSAKA GENERAL HOSPITAL   (Japan)

Author keywords

Contrast induced acute kidney injury; Primary percutaneous coronary intervention; Renal insufficiency; ST segment elevation myocardial infarction

Indexed keywords

CREATININE;

ACUTE KIDNEY FAILURE; AGED; ARTICLE; CONTRAST INDUCED NEPHROPATHY; CREATININE BLOOD LEVEL; FEMALE; GLOMERULUS FILTRATION RATE; HEMODYNAMIC PARAMETERS; HOSPITAL DISCHARGE; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; OUTCOME ASSESSMENT; PERCUTANEOUS CORONARY INTERVENTION; PREDICTOR VARIABLE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; RISK FACTOR; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; SURVIVOR;

CONTRAST-INDUCED ACUTE KIDNEY INJURY; PRIMARY PERCUTANEOUS CORONARY INTERVENTION; RENAL INSUFFICIENCY; ST-SEGMENT ELEVATION MYOCARDIAL INFARCTION;

ACUTE KIDNEY INJURY; AGED; BIOLOGICAL MARKERS; CHI-SQUARE DISTRIBUTION; CONTRAST MEDIA; CORONARY ANGIOGRAPHY; CREATININE; DISEASE-FREE SURVIVAL; FEMALE; GLOMERULAR FILTRATION RATE; HUMANS; INCIDENCE; JAPAN; KAPLAN-MEIER ESTIMATE; KIDNEY; LOGISTIC MODELS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; MYOCARDIAL INFARCTION; ODDS RATIO; PATIENT DISCHARGE; PERCUTANEOUS CORONARY INTERVENTION; PROPORTIONAL HAZARDS MODELS; RENAL INSUFFICIENCY; RETROSPECTIVE STUDIES; RISK FACTORS; TIME FACTORS; TREATMENT OUTCOME; UP-REGULATION;

EID: 84883803468     PISSN: 15538389     EISSN: 18780938     Source Type: Journal    
DOI: 10.1016/j.carrev.2013.07.009     Document Type: Article

References (24)

1. Takii T., Yasuda S., Takahashi J., Ito K., Shiba N., Shirato K., et al. Trends in acute myocardial infarction incidence and mortality over 30years in Japan: report from the MIYAGI-AMI Registry Study. Circ J 2010, 74:93-100. MIYAGI-AMI Study Investigators.
2. Marenzi G., Lauri G., Assanelli E., Campodonico J., De Metrio M., Marana I., et al. Contrast-induced nephropathy in patients undergoing primary angioplasty for acute myocardial infarction. J Am Coll Cardiol 2004, 44:1780-1785.
3. Rihal C.S., Textor S.C., Grill D.E., Berger P.B., Ting H.H., Best P.J., et al. Incidence and prognostic importance of acute renal failure after percutaneous coronary intervention. Circulation 2002, 105:2259-2264.
4. Lindsay J., Apple S., Pinnow E.E., Gevorkian N., Gruberg L., Satler L.F., et al. Percutaneous coronary intervention-associated nephropathy foreshadows increased risk of late adverse events in patients with normal baseline serum creatinine. Catheter Cardiovasc Interv 2003, 59:338-343.
5. McCullough P.A. Contrast-induced acute kidney injury. J Am Coll Cardiol 2008, 51:1419-1428.
6. Mehran R., Aymong E.D., Nikolsky E., Lasic Z., Iakovou I., Fahy M., et al. A simple risk score for prediction of contrast-induced nephropathy after percutaneous coronary intervention: development and initial validation. J Am Coll Cardiol 2004, 44:1393-1399.
7. Saltzman A.J., Stone G.W., Claessen B.E., Narula A., Leon-Reyes S., Weisz G., et al. Long-term impact of chronic kidney disease in patients with ST-segment elevation myocardial infarction treated with primary percutaneous coronary intervention: the HORIZONS-AMI (Harmonizing Outcomes With Revascularization and Stents in Acute Myocardial Infarction) trial. J Am Coll Cardiol Intv 2011, 4:1011-1019.
8. Mehran R., Nikolsky E., Lansky A.J., Kirtane A.J., Kim Y.H., Feit F., et al. Impact of chronic kidney disease on early (30-day) and late (1-year) outcomes of patients with acute coronary syndromes treated with alternative antithrombotic treatment strategies: an ACUITY (Acute Catheterization and Urgent Intervention Triage strategY) substudy. J Am Coll Cardiol Intv 2009, 2:748-757.
9. Sørensen C.R., Brendorp B., Rask-Madsen C., Køber L., Kjøller E., Torp-Pedersen C. The prognostic importance of creatinine clearance after acute myocardial infarction. Eur Heart J 2002, 23:948-952.
10. Solomon R., Dauerman H.L. Contrast-induced acute kidney injury. Circulation 2010, 122:2451-2455.
11. Marenzi G., Assanelli E., Campodonico J., Lauri G., Marana I., De Metrio M., et al. Contrast volume during primary percutaneous coronary intervention and subsequent contrast-induced nephropathy and mortality. Ann Intern Med 2009, 150:170-177.
12. Tumlin J., Stacul F., Adam A., Becker C.R., Davidson C., Lameire N., et al. Pathophysiology of contrast-induced nephropathy. Am J Cardiol 2006, 6A:14K-20K. CIN Consensus Working Panel.
13. Roy P., Raya V., Okabe T., Pinto Slottow T.L., Steinberg D.H., Smith K., et al. Incidence, predictors, and outcomes of post-percutaneous coronary intervention nephropathy in patients with diabetes mellitus and normal baseline serum creatinine levels. Am J Cardiol 2008, 101:1544-1549.
14. Lindsay J., Apple S., Pinnow E.E., Gevorkian N., Gruberg L., Satler L.F., et al. Percutaneous coronary intervention-associated nephropathy foreshadows increased risk of late adverse events in patients with normal baseline serum creatinine. Cathet Cardiovasc Intervent 2003, 59:338-343.
15. Cockcroft D.W., Gault M.H. Prediction of creatinine clearance from serum creatinine. Nephron 1976, 16:31-41.
16. Matsuo S., Imai E., Horio M., Yasuda Y., Tomita K., Nitta K., et al. Revised equations for estimated GFR from serum creatinine in Japan. Am J Kidney Dis 2009, 53:982-992.
17. Taglieri N., Koenig W., Kaski J.C. Cystatin C and cardiovascular risk. Clin Chem 2009, 55:1932-1943.
18. K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis 2002, 39(2 Suppl 1):S1-S266.
19. Robert A.M., Brown J.R., Sidhu M.S., Ramanath V.S., Devries J.T., Jayne J.E., et al. Dartmouth Dynamic Registry Investigators. The evaluation of creatinine clearance, estimated glomerular filtration rate and serum creatinine in predicting contrast-induced acute kidney injury among patients undergoing percutaneous coronary intervention. Cardiovasc Revasc Med 2012, 1:3-10.
20. McCullough P.A. Why is chronic kidney disease the "spoiler" for cardiovascular outcomes?. J Am Coll Cardiol 2003, 41:725-728.
21. Anzai A., Anzai T., Naito K., Kaneko H., Mano Y., Jo Y., et al. Prognostic significance of acute kidney injury after reperfused ST-elevation myocardial infarction: synergistic acceleration of renal dysfunction and left ventricular remodeling. J Cardiac Fail 2010, 16:381-389.
22. Busch S.V., Jensen S.E., Rosenberg J., Gögenur I. Prevention of contrast-induced nephropathy in STEMI patients undergoing primary percutaneous coronary intervention: a systematic review. J Interv Cardiol 2013, 1:97-105.
23. Ueda H., Yamada T., Masuda M., Okuyama Y., Morita T., Furukawa Y., et al. Prevention of contrast-induced nephropathy by bolus injection of sodium bicarbonate in patients with chronic kidney disease undergoing emergent coronary procedures. Am J Cardiol 2011, 107:1163-1167.
24. Masuda M., Yamada T., Mine T., Morita T., Tamaki S., Tsukamoto Y., et al. Comparison of usefulness of sodium bicarbonate versus sodium chloride to prevent contrast-induced nephropathy in patients undergoing an emergent coronary procedure. Am J Cardiol 2007, 100:781-786.